Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05062369 · ClinicalTrials.gov registry record · NA

Tdcs And cogNitive traininG cOmbined for AUD (TANGO)

A NA study of Alcohol Use Disorder and Addiction, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05062369 is a NA study of Alcohol Use Disorder and Addiction that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 40 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05062369, a NA study of Alcohol Use Disorder and Addiction, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The overarching goal of this project is to expand the traditional expertise in non-invasive neuromodulation at the University of Minnesota towards developing novel paired-neuromodulation approaches using transcranial direct current stimulation (tDCS) for new treatments for alcohol use disorder (AUD) that support long-term abstinence. This study will allow the investigators to discern whether the pairing of dorsolateral prefrontal cortex (DLPFC) stimulation and cognitive training can lead to improved treatment outcomes as it pertains to executive functioning and maintenance of abstinence. This paired-neuromodulation approach can potentially be used as a therapeutic intervention to decrease relapse probability in addiction. The long-term goal is to develop new addiction treatments that support long-term abstinence. The exploratory goal of this research is to associate genotypes and epigenetic changes with variations in intervention response and clinical outcome. Individual differences in baseline genetic profiles or epigenetic changes over the course of treatment could be associated with treatment response variability.

Conditions Studied

Alcohol Use Disorder Addiction

Interventions

  • DEVICE TaskFlow Transcranial Electrical Stimulation device
  • BEHAVIORAL Executive Function Focused Cognitive Training

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-03-03
Est. Completion 2027-09-30
Phase NA

Sponsor

University of Minnesota

966 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05062369

The ClinicalTrials.gov registry entry for NCT05062369 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (88% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which TaskFlow Transcranial Electrical Stimulation device is the first listed.

NCT05062369 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05062369 about?

NCT05062369 is a clinical study titled "Tdcs And cogNitive traininG cOmbined for AUD (TANGO)". The overarching goal of this project is to expand the traditional expertise in non-invasive neuromodulation at the University of Minnesota towards developing novel paired-neuromodulation approaches using transcranial direct current stimulation (tDCS) for new treatments for alcohol use disorder (AUD)...

What is the current status of trial NCT05062369?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-03-03. Estimated completion is 2027-09-30.

What conditions does trial NCT05062369 study?

This clinical trial studies the following conditions: Alcohol Use Disorder, Addiction.

What interventions are being tested in trial NCT05062369?

The interventions under investigation include: TaskFlow Transcranial Electrical Stimulation device (DEVICE), Executive Function Focused Cognitive Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05062369?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05062369 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alcohol Use Disorder

All registered trials for this condition

Addiction

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.